Nolan Sigal
Investitore di Private Equity presso Alerce Investment Management LP
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Nolan Sigal
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Alerce Investment Management LP
 Alerce Investment Management LP Investment ManagersFinance Alerce Investment Management LP (Alerce Investment) is a venture capital subsidiary of Satter Investment Management LLC founded by Muneer Satter. The firm is headquartered in Chicago, Illinois. | Investitore di Private Equity | 01/12/2017 | - |
Storia della carriera di Nolan Sigal
Precedenti posizioni note di Nolan Sigal
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AILERON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 02/04/2019 | 29/02/2024 |
| Independent Dir/Board Member | 02/04/2019 | 29/02/2024 | |
Tunitas Therapeutics, Inc.
 Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 01/01/2007 | 01/12/2017 |
| Amministratore Delegato | 01/01/2007 | 01/12/2017 | |
| Fondatore | 01/01/2007 | 01/12/2017 | |
| Presidente | 01/01/2007 | 01/12/2017 | |
Clearant, Inc.
 Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Direttore/Membro del Consiglio | - | 25/04/2007 |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Presidente | 01/01/2004 | 01/01/2007 |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01/12/1993 | 01/10/1999 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/09/1983 | 01/12/1993 |
| University of Toronto | Corporate Officer/Principal | 01/01/1980 | 01/09/1984 |
| Pharmacopeia, Inc. /Old/ | Corporate Officer/Principal | - | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Nolan Sigal
| Princeton University | Undergraduate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 12 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| President | 2 |
Settori
| Health Technology | 8 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Clearant, Inc.
Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Health Technology |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Alerce Investment Management LP
Alerce Investment Management LP Investment ManagersFinance Alerce Investment Management LP (Alerce Investment) is a venture capital subsidiary of Satter Investment Management LLC founded by Muneer Satter. The firm is headquartered in Chicago, Illinois. | Finance |
| Pharmacopeia, Inc. /Old/ | Commercial Services |
- Borsa valori
- Insiders
- Nolan Sigal
- Esperienza
